Get started
Author

Victor P. Carlo

Observed names: V. Carlo, Victor P Carlo
ORCID: 0009-0002-2519-5994
Observed ORCID: 0009-0002-2519-5994
OpenAlex ID: A5085948598
Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers
2006 · Laura C. Collins, Victor P. Carlo, et al. · The American Journal of Surgical Pathology · 200
Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al. · Molecular Cancer Therapeutics · 10
PDF
Incidental finding of a gastric schwannoma: a case report
2021 · Nelimar Cruz Centeno, Albert Suarez Dominguez, et al. · Journal of Surgical Case Reports · 9
Supplementary Table 1 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2026 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Figure S1 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2026 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Figure S2 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2026 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Abstract PS1-11-12: Rac/cdc42 inhibitor MBQ-167 in the estrogen receptor positive breast cancer tumor microenvironment
2026 · A. Cruz Collazo, N. Zaragoza-Rodriguez, et al. · Clinical Cancer Research
Rac/Cdc42 inhibitors target pancreatic cancer cells and macrophages in the tumor microenvironment
2026 · Anamaris Torres-Sanchez, Stephanie Dorta-Estremera, et al. · Cancer Treatment and Research Communications
Data from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Supplementary Table 2 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Figure S3 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Figure S2 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Supplementary Table 1 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Figure S1 from Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel
2024 · Ailed M. Cruz-Collazo, Olga Katsara, et al.
Abstract 7628: Pharmacodynamic biomarkers for Rac and Cdc42 inhibitor efficacy
2024 · Anamaris Torres-Sanchez, Ailed M. Cruz-Collazo, et al. · Cancer Research
Abstract 2462: Rac and p-PAK expression among Puerto Rican breast cancer patients
2022 · Mariangeline I. Gonzalez Ortiz, Magaly Martinez-Ferrer, et al. · Cancer Research
Works count: 16
Citation count: 219
H-index: 3
I10-index: 2
Year
Topic
Type